Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

The spray – which was approved by the FDA in March – has a wholesale acquisition cost of $295 per 28 mg device and costs around $32,400 for a year’s treatment, says ICER.

In April, she’d begun to use a topical nasal-spray decongestant. The over-the-counter (OTC) drug worked like a charm. By summer, she was still using the spray daily. Yet it was helping for ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

Using effective, FDA-approved TMS and Spravato nasal spray treatments, we help clients find relief from debilitating depression and anxiety when traditional antidepressants and therapy have fallen ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. When Dr. Husseini Manji was developing the first-in ...

Nasacort 24HR Allergy Nasal Spray is the first product Dr. Randolph Betts, MD, a family medicine practitioner based in California, recommends for nasal congestion. He notes that almost all his ...

Presentations include new data supporting the safety and efficacy of SPRAVATO® (esketamine) CIII nasal spray and the Company's innovative portfolio of long-acting injectables (LAIs) for ...

A team of researchers at Brigham and Women’s Hospital has created a nasal spray that promises to offer broad-spectrum protection against assorted respiratory infections, such as COVID-19, influenza, ...

Key presentations include: New five-year, real-world safety data from nearly 35,000 adults treated with SPRAVATO ®, building on more than a decade of research and reinforcing its well-studied ...

Presentations include new data supporting the safety and efficacy of SPRAVATO ® (esketamine) CIII nasal spray and the Company’s innovative portfolio of long-acting injectables (LAIs) for schizophrenia ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Esketamine nasal spray (Spravato) monotherapy was helpful in improving symptoms of treatment-resistant depression ...